Nexchain, and Bitcoin Hyper compare for 2026, covering private markets, AI blockchains, and Bitcoin Layer-2 growth.
Pharmaceutical Technology on MSN
Aktis Oncology kicks 2026 IPO cycle off with $210m target
According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...
A potential initial public offering (IPO) next year by cryptocurrency exchange Kraken may attract fresh capital from traditional finance (TradFi) investors. Bitcoin recorded an all-time high price ...
Kraken’s pending IPO and the wave of crypto companies seeking public listings may help the industry attract more TradFi capital. A potential initial public offering (IPO) next year by cryptocurrency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback